These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 4707702)

  • 1. Insulin binding and free insulin in serum of insulin-treated diabetics.
    Lev-Ran A; Ratt L
    Horm Metab Res; 1973 Mar; 5(2):67-70. PubMed ID: 4707702
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
    Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
    Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in daily insulin requirement in diabetics switched to monocomponent insulin treatment].
    Bruni B; Turco GL
    Minerva Med; 1973 Nov; 64(80):4224-31. PubMed ID: 4765430
    [No Abstract]   [Full Text] [Related]  

  • 4. Behaviour of insulin antibodies in diabetics treated with different insulins.
    Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
    Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of free and antibody-bound insulin in insulin treated diabetic patients.
    Heding LG
    Horm Metab Res; 1969 May; 1(3):145-6. PubMed ID: 5408729
    [No Abstract]   [Full Text] [Related]  

  • 6. [The study of insulin antibodies in different forms of diabetes mellitus].
    Mincu I; Ionescu-Tirgovişte C; Cheţa D; Simionescu L; Mirodon Z; Vasilescu V; Bruckner I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):421-8. PubMed ID: 44565
    [No Abstract]   [Full Text] [Related]  

  • 7. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
    Anderson OO
    Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum levels of insulin-binding antibodies treated with monocomponent insulin].
    Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
    Pol Tyg Lek; 1974 Feb; 29(8):301-4. PubMed ID: 4856084
    [No Abstract]   [Full Text] [Related]  

  • 9. [KH metabolic pattern and insulin antibody level during treatment of diabetes mellitus with conventional and/or prepurified insulin preparations].
    Göbel P; Kramer W; Heni F
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1426-9. PubMed ID: 611859
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term clinical trial with porcine monocomponent lente insulin (Monotard).
    Bruni B; Bruni Bocher K; Gamba S; Giolitti A; Rittatore R; Turco GL
    Panminerva Med; 1977; 19(4):247-54. PubMed ID: 593701
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experiences with monocomponent insulins].
    Bruni Bocher K; Giolitti A; Turco GL; Benedetto P; Bruni B
    Minerva Med; 1975 Mar; 66(19):909-30. PubMed ID: 1124144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular size of insulin-anti-insulin immune complexes in the serum of diabetic patients].
    Brizzio AM; Nieto RR; Cedola N; Poskus E; Gagliardino JJ
    Medicina (B Aires); 1988; 48(2):113-9. PubMed ID: 3068475
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioimmunoelectrophoresis in the determination of insulin binding to IgG.
    Christiansen AH
    Horm Metab Res; 1973 May; 5(3):147-54. PubMed ID: 4736627
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma immunoreactive insulin patterns in insulin-treated diabetics. Studies during continuous blood glucose monitoring.
    Molnar GD; Taylor WF; Langworthy AL
    Mayo Clin Proc; 1972 Oct; 47(10):709-19. PubMed ID: 4635563
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin treatment does not induce glucagon antibodies.
    Thomsen HG
    Horm Metab Res; 1971 Jan; 3(1):57-8. PubMed ID: 5128330
    [No Abstract]   [Full Text] [Related]  

  • 16. [Free, total and antibody-bound insulin content in newly detected diabetes mellitus patients].
    Mosin VI; Morozova NN; Salanda BS
    Probl Endokrinol (Mosk); 1980; 26(5):6-11. PubMed ID: 7001439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fatty diabetes, insulin resistance and anti-insulin antibodies].
    Jacotot B; Navarro N; Delplanque B; Le Parco JC; Beaumont JL
    Nouv Presse Med; 1973 Apr; 2(17):1121-4. PubMed ID: 4707009
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma proinsulin-like material in insulin treated diabetics.
    Fink G; Cresto JC; Gutman RA; Lavine RL; Rubenstein AH; Recant L
    Horm Metab Res; 1974 Nov; 6(6):439-43. PubMed ID: 4452543
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin antibodies in aetiology of labile diabetes.
    Dixon K; Exon PD; Hughes HR
    Lancet; 1972 Feb; 1(7746):343-7. PubMed ID: 4109736
    [No Abstract]   [Full Text] [Related]  

  • 20. Combinations of oral hypoglycemic drugs in obese, insulin-resistant diabetics.
    Fineberg SK
    Geriatrics; 1968 Sep; 23(9):137-46. PubMed ID: 5673663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.